Raymond James reiterates Black Diamond stock rating on Q2 results — See source for full details.
$BDTX
Price history, market instrument context, member research, and related headlines in one place.
BDTX key statistics
NasdaqGSUSD
52-week range
$1.604%$4.94
Latest session $1.67–$1.74Black Diamond Therapeutics, Inc. (BDTX) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $1.74, up $0.04 (2.35%) from the previous close of $1.70. It has traded between $1.67 and $1.74 in the latest session. Over the past year it has ranged from $1.60 to $4.94, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 614.4K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
TD Cowen reiterates Buy on Black Diamond stock after Q2 results — See source for full details.
Black Diamond Group (TSE:BDI) reported second-quarter 2026 revenue growth driven by recurring rental and lodging services, while adjusted EBITDA rose at a slower pace as the company’s revenue mix shifted following its acquisition of Royal Camp Services. Consolidated revenue increased 23% year over
Loading $BDTX research…